Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 3
2017 1
2018 2
2019 2
2020 1
2022 1
2023 1
2024 2
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Oligoclonal bands.
Willis MD, Kreft KL, Dancey B. Willis MD, et al. Pract Neurol. 2024 Sep 13;24(5):400-406. doi: 10.1136/pn-2023-003814. Pract Neurol. 2024. PMID: 38937092 Review.
Alemtuzumab for Multiple Sclerosis.
Willis MD, Robertson NP. Willis MD, et al. Curr Neurol Neurosci Rep. 2016 Sep;16(9):84. doi: 10.1007/s11910-016-0685-y. Curr Neurol Neurosci Rep. 2016. PMID: 27485945 Free PMC article. Review.
Alemtuzumab for the treatment of multiple sclerosis.
Willis MD, Robertson NP. Willis MD, et al. Ther Clin Risk Manag. 2015 Mar 31;11:525-34. doi: 10.2147/TCRM.S80112. eCollection 2015. Ther Clin Risk Manag. 2015. PMID: 25848299 Free PMC article. Review. No abstract available.
Clinical observation during alemtuzumab administration.
Allen CM, Feng JJ, Willis MD, McGinley M, Ontaneda D, Tallantyre EC, Evangelou N. Allen CM, et al. Among authors: willis md. Mult Scler Relat Disord. 2020 Jan;37:101412. doi: 10.1016/j.msard.2019.101412. Epub 2019 Sep 25. Mult Scler Relat Disord. 2020. PMID: 32172992 No abstract available.
Contemporary study of multiple sclerosis disability in South East Wales.
Harding KE, Ingram G, Tallantyre EC, Joseph F, Wardle M, Pickersgill TP, Willis MD, Tomassini V, Pearson OR, Robertson NP. Harding KE, et al. Among authors: willis md. J Neurol Neurosurg Psychiatry. 2023 Apr;94(4):272-279. doi: 10.1136/jnnp-2022-330013. Epub 2022 Nov 3. J Neurol Neurosurg Psychiatry. 2023. PMID: 36328420
How common is truly benign MS in a UK population?
Tallantyre EC, Major PC, Atherton MJ, Davies WA, Joseph F, Tomassini V, Pickersgill TP, Harding KE, Willis MD, Winter M, Robertson NP. Tallantyre EC, et al. J Neurol Neurosurg Psychiatry. 2019 May;90(5):522-528. doi: 10.1136/jnnp-2018-318802. Epub 2018 Sep 3. J Neurol Neurosurg Psychiatry. 2019. PMID: 30177509 Free PMC article.
Targeted suppression of autoreactive CD8+ T-cell activation using blocking anti-CD8 antibodies.
Clement M, Pearson JA, Gras S, van den Berg HA, Lissina A, Llewellyn-Lacey S, Willis MD, Dockree T, McLaren JE, Ekeruche-Makinde J, Gostick E, Robertson NP, Rossjohn J, Burrows SR, Price DA, Wong FS, Peakman M, Skowera A, Wooldridge L. Clement M, et al. Among authors: willis md. Sci Rep. 2016 Oct 17;6:35332. doi: 10.1038/srep35332. Sci Rep. 2016. PMID: 27748447 Free PMC article.